Both experimental and epidemiologic studies have linked a low dietary intake of selenium with an increased risk of cancer. The authors examined the association between plasma selenium levels and risk of hepatocellular carcinoma (HCC) among chronic carriers of hepatitis B and/or C virus in a cohort of 7,342 men in Taiwan who were recruited by personal interview and blood draw during 1988-1992. After these men were followed up for an average of 5.3 years, selenium levels in the stored plasma were measured by using hydride atomic absorption spectrometry for 69 incident HCC cases who were positive for hepatitis B surface antigen (HBsAg) and/or antibodies against hepatitis C virus (mostly HBsAg positive) and 139 matched, healthy controls who were HBsAg positive. Mean selenium levels were significantly lower in the HCC cases than in the HBsAg-positive controls (p = 0.01). Adjusted odds ratios of HCC for subjects in increasing quintiles of plasma selenium were 1.00, 0.52, 0.32, 0.19, and 0.62, respectively. The inverse association between plasma selenium levels and HCC was most striking among cigarette smokers and among subjects with low plasma levels of retinol or various carotenoids. There was no clear evidence for an interaction between selenium and a-tocopherol in relation to HCC risk. Am J Epidemiol 1999; 150:367-74. 
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carcinoma; carcinoma, hepatocellular; carotenoids; hepatitis B; hepatitis C; selenium; smoking; vitamin A Hepatocellular carcinoma (HCC) is a highly malignant neoplasm with an extremely poor prognosis. Although chronic hepatitis B virus infection is the major cause of at least 80 percent of HCC throughout the world, only a minority of the carriers of this infection are expected to develop HCC during their lifetimes (1, 2) . In addition to chronic infection with hepatitis B virus, hepatitis C virus, aflatoxin exposure, alcohol drinking, and cigarette smoking have been reviewed extensively for their associations with HCC (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . However, very little attention has been paid to the role of dietary factors besides aflatoxins in human hepatocarcinogenesis (7, 10, 11) .
Selenium is a component of the enzyme glutathione peroxidase, which plays an important role in the body's antioxidant defense against the deleterious effects of free radicals (12, 13) . There is convincing evidence that free-radical-mediated DNA damage is a significant factor in the etiology of cancer (13) . The majority of animal studies related to selenium and cancer have reported a protective effect of selenium, including inhibition of carcinogen-induced hepatocarcinogenesis (14) (15) (16) (17) (18) (19) (20) . Geographic correlation studies of humans have demonstrated that cancer mortality rates are higher in regions with low levels of selenium in forage crops and in serum than in regions with high levels of selenium (21, 22) . Prospective studies carried out among populations with a low or moderate selenium intake have found an inverse association between selenium levels in the blood or toenails and cancer at all sites combined and at specific sites, especially the lung and stomach (23) (24) (25) (26) . Several authors have suggested that the increased cancer risk in relation to low selenium status is more pronounced in men than in women (24) (25) (26) . However, prospective studies of selenium and cancer in populations with a high selenium intake have yielded inconsistent results (27) (28) (29) (30) (31) . None of these studies has focused specifically on HCC.
Taiwan is a hyperendemic area of hepatitis B virus infection, with a chronic carrier rate of as high as 15-20 percent (1-3). The prevalence of antibodies against hepatitis C virus (anti-HCV) in the general population of Taiwan is less than 2 percent (2, 3).
Approximately 80 percent of the HCC that occurs in this high-risk area is attributable to chronic infection with hepatitis B and/or C virus (2, 3) . Chronic infection by viruses results in chronic phagocytic activity, which is one of the major endogenous sources contributing to most of the free radicals produced by cells (13) . We investigated the associations of blood levels of retinol and various carotenoids with HCC by using a nested case-control study design, and the results suggest that high levels of these micronutnents may be associated with a decreased risk of HCC in relation to chronic hepatitis B virus infection, cigarette smoking, and/or alcohol drinking (10, 11) . The present study was based on a long-term prospective study and was undertaken to assess the importance of selenium status in hepatocarcinogenesis among men with chronic hepatitis B and/or C virus infections. Since the functions of selenium and other antioxidant micronutrients, such as retinol, various carotenoids, and a-tocopherol, overlap (13) , it is conceivable that the relation between selenium status and HCC is influenced by the status of other antioxidants. Our study also addressed this possible interactive effect.
MATERIALS AND METHODS

Study subjects
The characteristics and method of cancer follow-up for the complete cohort or part of the cohort in this study have been described previously (4, 5, 9, 11, 32) . Between August 1988 and June 1992, a cohort of men aged 30-65 years, 4,841 asymptomatic hepatitis B surface antigen (HBsAg) carriers and 2,501 noncarriers, was recruited from the Government Employee Central Clinics and the Liver Unit of Chang-Gung Memorial Hospital in Taipei, Taiwan. At recruitment, each study participant was interviewed in person to obtain information on demographic characteristics, cigarette smoking, alcohol drinking, frequency of consumption of various food items, and personal and family histories of major diseases. Fasting blood samples were collected from all study participants. Aliquots of plasma, serum, and buffy coat separated from blood samples were stored at -70°C until subsequent analyses. This study was approved by the Department of Health, Executive Yuan.
All HBsAg carriers were scheduled to undergo both an a-fetoprotein measurement and an ultrasonography examination every 6-12 months. Abdominal ultrasonography was performed by experienced gastroenterologists. Any subject who had an ultrasonographic image that was compatible with HCC and/or an elevated a-fetoprotein level (>20 ng/ml) was referred for further confirmatory diagnosis. After each follow-up examination, approximately 70 percent of the surviving HBsAg carriers continued to return for examination. HBsAg noncarriers and HBsAg carriers who did not participate in the follow-up examinations were followed up by interviewing them by telephone and by linking data with the computer files of national cancer and death registry systems. When a case of HCC was identified, permission was sought from the hospital where the subject was diagnosed with cancer to obtain the medical charts and pathology reports. A final diagnosis of HCC was based on 1) positive findings from pathologic or cytologic examinations and/or 2) an elevated a-fetoprotein level (>400 ng/ml) combined with at least one positive image from angiography, sonography, and/or computed tomography.
During an average of 5.3 years of follow-up, 73 incident cases of HCC were ascertained. Fifty-three were identified by means of periodic follow-up examinations and 20 through secondary sources of information including death records and reports from the national cancer registry system. Excluded from analysis were 4 cases with insufficient plasma samples for selenium assay, which left a total of 69 HCC cases in this study. Almost all HCC cases were HBsAg carriers; the 2 HBsAg-negative cases were positive for anti-HCV. Of the 67 HBsAg-positive HCC cases, 7 had insufficient serum samples for anti-HCV assay, and 5 were also anti-HCV positive.
HBsAg-positive controls were chosen at random from cohort members who remained unaffected with HCC throughout the follow-up period. They were matched with HCC cases on the basis of age (±5 years), recruitment clinic, and date of questionnaire interview and blood collection (within 3 months). HBsAg-negative controls were also chosen from the same cohort according to this matching process to evaluate the effect of chronic hepatitis B virus infection on plasma selenium levels.
Laboratory analyses
Serum HBsAg was tested by radioimmunoassay (Abbott Laboratories, North Chicago, Illinois). A second-generation enzyme immunoassay (Abbott Laboratories) was used to detect anti-HCV. Plasma levels of retinol, a-tocopherol, and various carotenoids were determined by high-performance liquid chromatography (33) . The between-run coefficients of variation were <5.0 percent for retinol and a-tocopherol, 5-6 percent for a-carotene and P-carotene, and 9-10 percent for lycopene.
Selenium levels were measured in plasma samples by flow injection hydride atomic absorption spectrometry using a modification of the method described by Negretti de Bratter et al. (34) . A Perkin-Elmer 3100 atomic absorption spectrometer equipped with a Perkin-Elmer FIAS-400 System was used (PerkinElmer Corporation, Norwalk, Connecticut). The calibration curve was built up by using standard reference material of human serum (Nyegaard, Oslo, Norway). For acid digestion, a 0.2 ml plasma aliquot or a 0.2 ml aliquot of the working standard solution was treated with 1 ml of a mixture of concentrated acid (HNO 3 :HC1O 4 = 4:1). The sample was digested on an electric oven for 2 hours at 160°C. When it cooled, the digested sample was adjusted to a final volume of 3 ml by using 7N HC1 and antifoam reagent and was reduced from Se (VI) to Se (TV). After hydride was generated by using a sodium borohydride method, the selenium content was determined.
The results from the analysis of standard reference materials matched the certified values. Spiking tests showed that the recovery was 94-109 percent for the method of selenium assay used. The method's coefficient of variation between days was 10 percent, and the detection limit was 5.0 (ig/liter. Duplicate specimens were assayed for each study subject, and the average of the two was used to indicate the selenium levels. Each analytical batch contained plasma samples from HCC patients and matched controls (including HBsAg-positive and HBsAg-negative controls). No systematic changes in the selenium levels of the reference sera were observed throughout the period of laboratory analysis. Laboratory personnel were kept blind to disease status.
Statistical methods
The chi-square test was used to examine differences in the distributions of categorical variables between groups. Statistical adjustment of the selenium value in plasma was performed by using the residual method (35) . The significance of differences in the adjusted selenium values by categories was assessed by using the t test or the F test, as appropriate. Selenium values were categorized as quintiles or tertiles on the basis of the distribution among all controls. Conditional logistic regression models were used to derive the matched crude and multivariate-adjusted odds ratios associated with HCC. In the stratified data analyses of the interactions of selenium with cigarette smoking and other micronutrients, unconditional logistic regression analysis was performed to estimate the odds ratios. Tests for trend in the odds ratios across tertiles of selenium levels were computed on the basis of likelihood ratio tests, with scores of 1-3 assigned to increasing tertiles of plasma selenium. We also used likelihood ratio tests to determine the statistical significance of the interactions between selenium and other factors with respect to HCC risk. These tests compared a "main effects, no interaction" model with a fully parameterized model containing all possible interaction terms for the variables of interest. All p values were calculated from twotailed tests of statistical significance.
RESULTS
The distributions of the groups studied, by selected baseline characteristics, are presented in table 1. There were no statistically significant differences between groups in the distributions of age, cigarette smoking, alcohol drinking, season of blood draw, and number of years since blood collection. Seventy-eight percent of the HBsAg-negative controls had an educational level of junior college or above, in contrast to approximately 50 percent of the subjects in the other two groups. The proportion of men who had a history of chronic liver disease was significantly higher among HCC cases than among the two control groups.
Among controls, there were no statistically significant Pearson's correlation coefficients for plasma selenium with plasma retinol (r = -0.04), oc-tocopherol (r = -0.02), a-carotene (r = -0.03), P-carotene (r = -0.04), and lycopene (r = -0.03). Furthermore, no statistically significant association with plasma selenium was found for age, educational level, cigarette smoking, alcohol drinking, season of blood draw, or number of years since blood collection. However, selenium levels declined slightly with age and were lower in smokers and drinkers. Because age, smoking, and alcohol abuse were associated with low selenium status in previous reports (23, 31, (36) (37) (38) , selenium values adjusted for these three factors were used when we compared the mean or median levels of selenium between groups. The adjusted mean and median values of plasma selenium for the groups studied are shown in table 2. There was no statistically significant difference in plasma selenium levels between HBsAg-positive and HBsAgnegative controls. HCC cases had significantly lower mean plasma levels of selenium than did HBsAgpositive controls (p = 0.01). When HCC cases were categorized by the year of follow-up in which they were diagnosed, there was no trend toward lower plasma levels in cases occurring early.
The odds ratios associated with HCC, by quintiles of plasma selenium among men with chronic hepatitis virus infection, are shown in table 3. All HCC cases but only HBsAg-positive controls were included in the analyses. In the multivariate analysis of the association between plasma selenium levels and HCC, we adjusted for age, cigarette smoking, alcohol drinking, and plasma levels of other micronutrients. The multivariate-adjusted odds ratios of HCC for increasing quintiles of plasma selenium were 1.00, 0.52, 0.32, 0.19, and 0.62, respectively. A similar pattern was observed after excluding subjects with a history of chronic liver disease; the odds ratios of HCC for increasing quintiles of plasma selenium were 1.00, 0.74, 0.60, 0.24, and 0.41, respectively (data not shown).
As shown in table 4, HCC cases were subdivided into two groups according to the median of the time between blood draw and cancer diagnosis. The odds ratio, by quintile of plasma selenium level, was estimated for each of the two groups of cases and matched controls. Within 2.8 years of blood draw, there was no significant association between plasma selenium and HCC, but a significant inverse association was found when statistical evaluation was restricted to the 35 cases diagnosed more than 2.8 years after the blood samples were collected. The multivariate-adjusted odds ratios of HCC associated with plasma selenium among men with chronic hepatitis virus infection, by category of cigarette smoking and plasma levels of retinol, a-tocopherol, and various carotenoids, are presented in table 5. A statistically significant inverse association was found between selenium and HCC among cigarette smokers and among subjects with low plasma levels of retinol or various carotenoids. A U-shaped relation between selenium and HCC was observed among smokers and among subjects with low plasma carotenoids. However, the HCC risk decreased monotonically with increasing levels of selenium in the low-retinol group (test for trend, p = 0.006). In any of the other groups, none of the odds ratios for tertiles of plasma selenium levels was statistically significantly different from unity. While a statistically significant modification of the selenium effect by retinol levels was found (test for interaction, p < 0.005), there were no statistically significant interactions between selenium and other factors.
DISCUSSION
Experimental studies indicate that selenium has anticarcinogenic properties. Mechanisms that may be involved in the protective effect of selenium include a reduction in the mutagenicity of carcinogens, inhibition of cell proliferation, and protection against oxidative damage via selenium-dependent glutathione peroxidase (12) (13) (14) (39) (40) (41) (42) . Selenium is also known to affect immune function (43) . In our study, we used a prospectively collected marker of selenium exposure and observed a statistically significant inverse association between plasma selenium levels and HCC among men with chronic hepatitis virus infection (mostly chronic hepatitis B virus carriers). This association cannot be explained on the basis of measured confounders.
A fraction of HCC patients may develop cancer after the onset of various chronic liver diseases (2, 32) . Lower plasma selenium levels in HCC cases may result from hepatic dysfunction, which may influence dietary intake, metabolism, and/or distribution of selenium; thus, lower levels of selenium among cases compared with controls may be a consequence rather than a cause of the disease. In support of this hypothesis is the observation that blood selenium levels have been shown to decrease in patients who have various clinical, chronic liver diseases largely caused by alcohol abuse, in which case selenium deficiency has been attributed to inadequate selenium intake (36) (37) (38) . However, most of the HCC patients in this study were asymptomatic chronic carriers of hepatitis B and/or C virus who had no history of chronic liver disease at recruitment. No statistically significant difference in the plasma selenium levels was observed between HBsAg-positive and HBsAg-negative controls. Exclusion of study subjects who had a history of chronic liver disease produced no substantial change in the pattern of the inverse relation between selenium and HCC. § The high and low levels of carotenoid were categorized according to the median value for all controls. For retinol and a-tocopherol, the cutoff values for low and high were based on the median values for HCC cases, because a small number of the cancer patients had plasma levels of these nutrients that were higher than the median for controls.
H The model included terms for age, alcohol drinking, and cigarette smoking. # Test for interaction between selenium and retinol was significant.
•• Test for trend was significant.
It also seems unlikely that the inverse association between plasma selenium and HCC can be explained by bias due to the effect of preclinical cancer, as we did not observe a significant association of selenium levels with time to diagnosis among HCC cases. In addition, the inverse association between selenium and HCC became stronger after we excluded the casecontrol matched sets in which the cases were diagnosed within 2.8 years of blood collection. However, 2.8 years of follow-up may be a relatively short period in which to assess the effect of preclinical cancer on plasma selenium levels. Analysis of the effect of preclinical cancer was based on the cutoff value of 2.8 years, the median of the time between blood draw and cancer diagnosis among cases, because of the limited follow-up period (only 5.3 years on average) and the small number of cases. A longer follow-up period will be needed to address this issue more definitively.
Although the results from several prospective studies agree with the hypothesis that a low selenium intake raises the risk of cancer, evidence of a doseresponse relation between selenium levels in blood or toenails and cancer has been inconsistent (23) (24) (25) (26) (27) (28) (29) . The discrepancies among these studies may result from the differences in sample sizes, the control of possible confounders, the ranges of selenium levels, the cancer sites studied, and/or the distributions of other nutritional factors or of exposures to environmental carcinogens between study populations. Selenium is an essential trace element, but it is toxic at high doses (13) . In the present investigation, the median level of plasma selenium in controls was approximately 140 (a.g/liter, which suggests that dietary selenium intake is not low in this study population. However, we observed an approximately sevenfold variation in plasma selenium levels among study subjects. Our data indicated no linear trend across quintiles of sele-nium levels for the risk of developing HCC. The lowest risk for HCC was found among subjects in the middle quintiles of plasma selenium. Because of the small number of HCC cases in this study, future studies should clarify whether the U-shaped relation between selenium and HCC is real or whether it resulted from sampling variation or chance.
Cigarette smoking has been associated with a moderately excess risk of HCC in populations with a high or low incidence of this disease (3, (6) (7) (8) (9) (10) (11) . However, the biologic mechanism by which cigarette smoking acts in the pathogenesis of HCC has not yet been evaluated comprehensively (8) (9) (10) (11) 32) . Tobacco smoke contains a variety of carcinogens with initiator and/or promoter properties (44) . It also induces oxidative stress, which is important in the pathogenesis of a wide range of degenerative diseases, including cancer and coronary heart disease (13) . In this study, we observed that the inverse association with selenium levels occurred largely among cigarette smokers, but the limited sample size made it difficult to demonstrate a statistically significant interactive effect of selenium and smoking on the development of HCC. As smoking was associated with low selenium status (23, 31) , the inverse association between selenium and HCC among cigarette smokers might therefore have been confounded by the intensity of exposure to cigarette smoke. However, the significant inverse association among cigarette smokers persisted even after close control of the intensity of smoking by using pack-years. There was no such association among nonsmokers.
There are limited data showing the effect of selenium on cancer risk among persons whose smoking habits differ. In probably the only prospective study carried out to assess the potential interaction of selenium with smoking in relation to lung cancer, the inverse association with selenium tended to be more prominent among heavy smokers than among light smokers and ex-smokers; however, no significant association between selenium and lung cancer risk was observed for any subgroup (23) . Results from previous prospective studies of selenium and cancer generally have been consistent with an inverse association that is more pronounced in men than in women (24) (25) (26) . Since the prevalence of cigarette smoking is much higher among men than women, and a large proportion of cancers in men are smoking related, it is reasonable to speculate that the gender-specific effect of selenium observed in earlier studies might at least partly reflect the difference in smoking history between the sexes.
With regard to the risk of cancer at all sites combined and of lung cancer, it has been suggested that an interaction exists between the effects of selenium and other antioxidant micronutrients, including vitamins A, C, and E and P-carotene (23, 25, 27) . Our previous nested case-control studies have demonstrated that low blood levels of retinol and various carotenoids are associated with an increased susceptibility to HCC (10, 11) . In the present study, the inverse association between selenium and HCC was particularly notable for subjects who had low plasma levels of retinol or various carotenoids. We observed a significant modification of the selenium effect by retinol level. Evidence also suggested an interaction between selenium and various carotenoids, although tests for such interactions were not statistically significant. However, no clear evidence was found for an interaction of atocopherol and selenium with HCC risk. A chemoprevention trial conducted in a region of China with extremely high rates of esophageal and stomach cancer reported a 13 percent reduction in cancer mortality as a result of supplementation with a combination of vitamin E, p-carotene, and selenium (45) . The efficacy of combining selenium with other nutrients to prevent HCC in chronic carriers of hepatitis B and/or C virus merits further study.
